News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novo Nordisk A/S (NVO) Files Annual Report With the SEC



2/9/2012 8:42:07 AM

BAGSVAERD, DENMARK--(Marketwire - February 08, 2012) -



Novo Nordisk A/S has filed its Annual Report 2011 on Form 20-F for the financial year 2011 with the US Securities and Exchange Commission (SEC), incorporating by reference parts of the Novo Nordisk A/S Annual Report 2011. The reports are available at the SEC's website,www.sec.gov as well as at novonordisk.com - Investors - Download centre (listed under 2011).

Shareholders and ADR holders may receive a hard copy of the annual reports free of charge upon request by filling out a request form at novonordisk.com/investors/download-centre or upon request to either tel no Tel: (+1) 609 786 4575 or by e-mail to jlis@novonordisk.com. When e-mailing, please state the exact mailing address and the document(s) you wish to receive



This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1583734]


Further information:

Media:

Anne Margrethe Hauge
Tel: (+45) 4442 3450
Email Contact

In North America:

Ken Inchausti
Tel: (+1) 609 514 8316
Email Contact

Jannick Lindegaard
Tel: (+1) 609 786 4575Investors:
Email Contact

Klaus Bulow Davidsen
Tel: (+45) 4442 3176
Email Contact

Frank Daniel Mersebach
Tel: (+45) 4442 0604
Email Contact

Lars Borup Jacobsen
Tel: (+45) 3075 3479
Email Contact


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES